Evidence map›Paper›PMID 29942042›Full record

ReviewMolecular psychiatry2019

A decade in psychiatric GWAS research.

Tanya Horwitz, Katie Lam, Yu Chen, Yan Xia, Chunyu Liu

Abstract readHistorical ArticleReview
In one paragraph

Review in Molecular psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Just a SNP away: The future ofCell insight · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tanya HorwitzDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Katie LamDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Yu ChenSchool of Life Science, Central South University, Changsha, China.
Yan XiaSchool of Life Science, Central South University, Changsha, China.
Chunyu LiuDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA. liuch@upstate.edu.ORCID http://orcid.org/0000-0002-5986-4415

Funding

Genetic variants affect brain gene expression and risks of psychiatric disordersU01MH103340 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI LIU, CHUNYU, RZHETSKY, ANDREY · 2014 to 2017
$4.3M
The Genetic and Genomic Study of MicroRNA in Bipolar and SchizophreniaR01MH080425 · NIMH · UNIVERSITY OF CHICAGO · PI LIU, CHUNYU · 2007 to 2010
$2.6M
1/2 Measuring translational dynamics and the proteome to identify potential brain biomarkers for psychiatric diseaseR01MH110920 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI LIU, CHUNYU · 2016 to 2019
$2.0M
Integrating epigenomic maps to predict regulatory functions of genetic variantsR01ES024988 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIU, CHUNYU · 2014 to 2015
$625k
NIEHS NIH HHS R01 ES024988NIMH NIH HHS R01 MH080425NIMH NIH HHS R01 MH103340NIMH NIH HHS R01 MH110920NIMH NIH HHS U01 MH103340
6 · The paper itself

Abstract

After more than 10 years of accumulated efforts, genome-wide association studies (GWAS) have led to many findings, most of which have been deposited into the GWAS Catalog. Between GWAS's inception and March 2017, the GWAS Catalog has collected 2429 studies, 1818 phenotypes, and 28,462 associated SNPs. We reclassified the psychology-related phenotypes into 217 reclassified phenotypes, which accounted for 514 studies and 7052 SNPs. In total, 1223 of the SNPs reached genome-wide significance. Of these, 147 were replicated for the same psychological trait in different studies. Another 305 SNPs were replicated within one original study. The SNPs rs2075650 and rs4420638 were linked to the most replications within a single reclassified phenotype or very similar reclassified phenotypes; both were associated with Alzheimer's disease (AD). Schizophrenia was associated with 74 within-phenotype SNPs reported in independents studies. Alzheimer's disease and schizophrenia were both linked to some physical phenotypes, including cholesterol and body mass index, through common GWAS signals. Alzheimer's disease also shared risk SNPs with age-related phenotypes such as age-related macular degeneration and longevity. Smoking-related SNPs were linked to lung cancer and respiratory function. Alcohol-related SNPs were associated with cardiovascular and digestive system phenotypes and disorders. Two separate studies also identified a shared risk SNP for bipolar disorder and educational attainment. This review revealed a list of reproducible SNPs worthy of future functional investigation. Additionally, by identifying SNPs associated with multiple phenotypes, we illustrated the importance of studying the relationships among phenotypes to resolve the nature of their causal links. The insights within this review will hopefully pave the way for future evidence-based genetic studies.

Indexed as

Alzheimer DiseaseFemaleGenetic Predisposition to DiseaseGenetic TestingGenome-Wide Association StudyGenotypeHistory, 20th CenturyHistory, 21st CenturyHumansMaleMental DisordersMental HealthPhenotypePolymorphism, Single NucleotideSchizophrenia

Identifiers

PMID29942042
PMCPMC6372350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.